The 20 Best Non-Alcoholic Fatty Liver Disease Doctors Near Me in Bronx, NY

Dr. Sanjaya K. Satapathy is the medical director of the Center for Liver Disease and Transplantation at the Northwell Transplant Institute, program director of Northwell's Transplant Hepatology Fellowship, and professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.His path to medicine began in India, where he was inspired by his father an engineer with a passion for homeopathy to pursue a career in healthcare. He earned his medical degree from Veer Surendra Sai Medical College, followed by fellowship training in gastroenterology and hepatology in the early 2000s. During that time, he witnessed the profound need for liver transplantation in India, where access remained scarce.While presenting his research at a conference in the United States, Dr. Satapathy was drawn to the opportunities and possibilities for advancing transplantation in America. He decided to continue his career in the United States, completing additional residency and fellowship training before serving as a transplant hepatologist in Memphis. In 2019, he was recruited to Northwell.It was a dream to begin from zero and build a transplant program that could be a model not just for the area or the state, but for the country, says Dr. Satapathy. Within only a few years, we've been able to achieve that goal, because Northwell has all the elements and resources to be one of the best programs in the nation. The expertise we have is unparalleled, with a collaborative team that encompasses all levels of care.The program was founded just in time for a huge surge in demand for liver transplants in the area, he adds. Liver disease and other liver issues are on the rise, making the need for an extensive program crucial for those in the New York region. Part of the program's strength is innovation. For example, Northwell is utilizing an approach that allows donated organs to be safely preserved for a longer period of time, which means needed organs can travel longer distances even from as far away as Hawaii. Northwell is also running several clinical trials on transplant medications and operates a robust transplant hepatology fellowship program to train the next generation of doctors a program Dr. Satapathy launched.I'm passionate about this work, and particularly about my patients, he says. I see every patient as my family, and my focus is on what I can do next to help them. Dr. Satapathy is rated as an Elite provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Spontaneous Bacterial Peritonitis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy. Dr. Satapathy is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Gastroenterology, and American Board Of Internal Medicine/Transplant Hepatology.

Scott Friedman is a Gastroenterologist practicing medicine in New York, New York. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cirrhosis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Hepatectomy.

Jonathan M. Schwartz is a board Certified Transplant Hepatologist.  He is a graduate of Tel Aviv University, Sackler School of Medicine. He was an Internal Medicine Resident at Albert Einstein College of Medicine and a Fellow in Gastroenterology/Transplant Hepatology at the University of Washington in Seattle.  He returned to New York in 2011 from Portland, Oregon where he served as an Associate Professor of Medicine at Oregon Health and Sciences University. Dr. Schwartz is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Primary Biliary Cholangitis, Reynolds Syndrome, and Budd-Chiari Syndrome. Dr. Schwartz is board certified in American Board Of IM/Gastroenterology.

Rebecca Roediger, MD, is an attending physician at Montefiore Einstein. Her clinical focus centers on transplant hepatology, alcohol-associated liver disease and viral hepatitis. Dr. Roediger is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Macroamylasemia, Non-Alcoholic Fatty Liver Disease, Visceromegaly, and Hepatitis.

Michael White is a Radiologist practicing medicine in Bronx, New York. Dr. White is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Visceromegaly, Cerebellar Multiple System Atrophy, and Bronchogenic Cyst.

Mordecai Koenigsberg, MD, is Director of Ultrasound and Director Emeritus of the Diagnostic Residency Program at Montefiore. He is also a Professor of Radiology at our Albert Einstein College of Medicine. Dr. Koenigsberg’s clinical focus is on ultrasound applications in diagnostic imaging. Dr. Koenigsberg is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Ureterocele, Visceromegaly, Scrotal Swelling, and Non-Alcoholic Fatty Liver Disease.

Kristina R. Chacko, MD, is an Associate Professor of Medicine at the Albert Einstein College of Medicine in Bronx, NY.  She joined the Einstein-Montefiore Liver Center in 2013 after completing a fellowship in Transplant Hepatology at Mount Sinai School of Medicine in New York, NY.  She received her bachelor of arts in philosophy at Boston College and attended medical school at Baylor College of Medicine in Houston, TX.  She completed her internal medicine residency at Emory University in Atlanta, GA, and gastroenterology fellowship at New York University.  Her clinical and research interests include the diagnosis and management of alcoholic hepatitis, non-alcoholic fatty liver disease, autoimmune liver diseases, and liver transplantation.  As the program director of the ACGME-accredited transplant hepatology fellowship at Montefiore Medical Center, she is directly involved in the development and execution of the hepatology curriculum for gastroenterology and hepatology fellows. Dr. Chacko is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Hepatitis, Visceromegaly, Autoimmune Hepatitis, Hepatitis C, and Liver Transplant.

Dr. Utpal Pajvani, Associate Professor of Medicine in the Division of Endocrinology at Columbia University, is a physician-scientist with clinical and research focus in Type 2 Diabetes and related metabolic diseases. He graduated from the Massachusetts Institute of Technology with a degree in Biology in 1996, then earned MS (2001), MD (2005) and PhD (Department of Cell Biology, 2005) degrees from the Albert Einstein College of Medicine. Dr. Pajvani completed his internship and residency training and is board certified in Internal Medicine (2007) and fellowship in Endocrinology, Diabetes & Metabolism (2011), both at the Columbia University Medical Center.Dr. Pajvani has been on the faculty of Columbia University since 2011. He is a teaching attending on the inpatient and outpatient Endocrinology and General Medicine services of the New York Presbyterian Hospital, and sees patients at the Naomi Berrie Diabetes Center at Columbia University. Dr. Pajvani is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Obesity, and Type 2 Diabetes (T2D). Dr. Pajvani is board certified in Internal Medicine and Endocrinology, Diabetes And Metabolism. Dr. Pajvani is currently accepting new patients.

Julia Wattacheril, MD, MPH is an associate professor of medicine, physician scientist, inventor and director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Irving Medical Center. Her clinical and translational work spans the multidisciplinary care of MASLD patients at all stages of their disease to the investigation of rare genetic variants influencing the development and progression of MASLD before and after liver transplantation. She currently leads an interdisciplinary research group using machine learning to identify at-risk and protected phenotypes within the electronic health record (EHR) for multi-omic analysis. Of particular interest for clinical outcomes discovered through EHR phenotyping include rapid progression to advanced liver disease, need for transplantation and hepatocellular carcinoma. Awards include the Department of Surgery Innovation Award and Columbia Department of Biomedical Engineering Ignition Award for these software applications as they move into medicine.Wattacheril is the lead principal investigator for several clinical trials in MASH. Her early pilot work with proteomics and lipidomics in the development of metabolic dysfunction associated steatohepatitis (MASH) led to her current efforts investigating multi-omic signatures associated with fibrotic MASH. She co-led a multicenter consortium investigating the clinical risks associated with the development of hepatocellular carcinoma in patients with all etiologies of chronic liver disease, with a particular local focus on diverse populations. At Columbia, she works closely with the Center for Precision Medicine and Genomics to integrate genomics into clinical care. She mentors across disciplines including computational geneticists to masters’ program students in nutrition to undergraduates in psychology. She has a commitment to community education, including faith-based and non-profit sectors. Dr. Wattacheril is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Visceromegaly, Enlarged Liver, Liver Transplant, and Endoscopy. Dr. Wattacheril is board certified in Gastroenterology and Transplant Hepatology. Dr. Wattacheril is currently accepting new patients.

Hillel Tobias is an Internal Medicine specialist and a Transplant Surgeon practicing medicine in New York, New York. Dr. Tobias is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Visceromegaly, Non-Alcoholic Fatty Liver Disease, and Liver Transplant. Dr. Tobias is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Gastroenterology.

Dr. Gendler has been practicing gastroenterology since 1988, and in the Westchester area since joining the staff of White Plains Hospital in 2013. He received his medical degree from Rush Medical College in Chicago and completed his Internal Medicine residency and fellowship training in gastroenterology at St. Luke's Roosevelt Hospital in New York. Immediately after fellowship, Dr. Gendler joined the staff of White Plains Hospital. To further his education, he spent a year as a visiting physician at Erasme Hospital, Universite de Brussels where he learned advanced techniques in lithotripsy for the management of gallstones and diagnostic and therapeutic biliary endoscopy (endoscopic retrograde cholangiopancreaticoscopy). Dr. Gendler is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Trichohepatoenteric Syndrome, Non-Alcoholic Fatty Liver Disease, Visceromegaly, Colonoscopy, and Endoscopy. Dr. Gendler is board certified in American Board Of Internal Medicine.

Jonathan Cohen is a graduate of Harvard College and Harvard Medical School. He completed his residency at Beth Israel Hospital in Boston, and fellowships in gastroenterology at UCLA, and advanced endoscopy at The Wellesley Hospital in Toronto, Canada. Dr. Cohen was Clinical Professor of Medicine at NYU School of Medicine since 2006, joining the full-time faculty as a Professor of Medicine at Northwell/Hofstra in 2024. He has worked as gastroenterologist and performed general and advanced endoscopy at Northwell Vanguard Gastroenterology with expertise in ERCP, colonoscopy, endoscopic resection of large polyps, ablation of tumors and Barrett's esophagus, weight management and endoscopic bariatric therapy. For each of the past 24 years, he has been named to the Castle Connolly Best Doctors list.Dr. Cohen the current Treasurer of the American Society for Gastrointestinal Endoscopy [ASGE] and will be the organization's President in 2027-8. He served as past Chairman of the ASGE Training Committee and the Quality Assurance in Endoscopy Committee. He is also the current Director of the Program for Endoscopic Teachers of the World Endoscopy Organization. Dr. Cohen served as President of the New York Society for Gastrointestinal Endoscopy in 2004. Dr. Cohen has authored numerous articles and has made many presentations at scientific meetings both in the U.S and abroad. He has edited three textbooks in his field: Successful Training in Endoscopy Endoscopy Past Present and Future: NYSGE at 50and Comprehensive Atlas of High-Resolution Endoscopy and Narrowband Imaging, a volume which has been translated into 4 languages and sold worldwide. Dr. Cohen is recognized by his colleagues around the world as an expert on quality indicators in gastroenterology, as well as simulator training and advanced imaging technologies in the early diagnosis of GI cancers. A sought after national and international lecturer, Dr. Cohen has also directed over 50 training courses in his fields of expertise to groups of doctors in many countries and throughout North America. He currently serves as Director of Innovation and Sustainability in the Northwell GI service line. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Gas Bloat Syndrome, Cronkhite-Canada Disease, and Juvenile Polyposis Syndrome. Dr. Cohen is board certified in American Board Of Internal Medicine/Gastroenterology.

Dr. Machineni obtained his medical degree from the All India Institute of Medical Sciences in New Delhi, followed by a residency in internal medicine at the State University of New York at  Buffalo. He served as chief resident and primary care teaching physician at Buffalo General Hospital. He subsequently completed a clinical and research fellowship in obesity medicine and metabolism at Massachusetts General Hospital/ Harvard Medical School and stayed on as an instructor. Dr. Machineni studied energy balance and body fat regulation in animal models allowing the interpretation of clinical research findings and phenotypes in the context of physiology. Dr. Machineni is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Obesity, Obesity in Children, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Gastric Bypass.

Shivani Agarwal, MD, MPH, is Director of the SEAD (Supporting Emerging Adults with Diabetes) program at Montefiore and an Assistant Professor of Medicine at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2018, her clinical focus has been on the treatment of type 1 and type 2 diabetes in patients aged 18 to 35 years old. Dr. Agarwal is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. Her clinical expertise encompasses Type 1 Diabetes (T1D), Non-Alcoholic Fatty Liver Disease, and Nonalcoholic Steatohepatitis (NASH).

Dr. Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics. Dr. Barzilai is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Abdominal Obesity Metabolic Syndrome.

Clara Y. Tow, MD, is Clinical Site Director, Hepatology, Associate Program Director, Gastroenterology & Liver Diseases Fellowship Program, Co-Course Director, Gastroenterology & Hepatology Systems Course and Assistant Professor, Medicine at Montefiore Einstein. Dr. Tow specializes in the treatment of complications of advanced liver diseases, liver cancer and liver transplant. She believes every patient is an integral part of the Montefiore Einstein family and that patient knowledge is power. Her goal is to provide patients and their families with the best medical care embedded in kindness, dignity and respect. Dr. Tow is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Hepatitis, Hepatitis C, Alcoholic Cirrhosis, Liver Failure, and Liver Transplant.

Anjali Manavalan is an Endocrinologist practicing medicine in Bronx, New York. Dr. Manavalan is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. Her clinical expertise encompasses Ectopic Cushing's syndrome, Panhypopituitarism, Low Blood Sugar, and Neurohypophyseal Diabetes Insipidus.

Harvey Rosenberg is a Gastroenterologist practicing medicine in Bronx, New York. Dr. Rosenberg is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. His clinical expertise encompasses Gastrointestinal Bleeding, Familial Adenomatous Polyposis, Esophageal Varices, Gastrectomy, and Colonoscopy.

Dr. Sandra Aleksic is an Assistant Professor in Department of Medicine, Division of Endocrinology and Geriatrics. She earned her medical degree from the University of Belgrade Faculty of Medicine in Serbia. She completed residency in internal medicine at Rutgers New Jersey Medical School and fellowship in endocrinology, diabetes and metabolism at Montefiore Medical Center/Albert Einstein College of Medicine. She earned a Master of Science in Clinical Research Methods through Einstein’s Clinical Research Training Program. She is the recipient of a Career Development Award from the Einstein/Montefiore Institute for Clinical and Translational Research, Resnick Emerging Scholar in Aging Research Award and Paul B. Beeson Emerging Leaders Career Development Award in Aging. Dr. Aleksic is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. Her clinical expertise encompasses Low Blood Sugar, Type 2 Diabetes (T2D), Isolated Hypogonadotropic Hypogonadism, and Hypogonadotropic Hypogonadism.

Justin Mathew is an Endocrinologist practicing medicine in Bronx, New York. Dr. Mathew is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. His clinical expertise encompasses Thyroid Storm, Type 1 Diabetes (T1D), Hyperthyroidism, and Hyperparathyroidism.